Survival Benefit Needed to Undergo Chemotherapy: Patients’ and Physicians’ Preferences: Patient and Physician Preferences instead of Patients’ and Physicians’ Preferences

BACKGROUND: Prior studies suggested that most patients with early stage breast cancer (BC) were willing, for modest survival benefits, to receive 6 months of adjuvant cyclophosphamide, methotrexate, and 5-fluorouracil, an older regimen that is infrequently used today. We examined preferences regardi...

Fuld beskrivelse

Na minha lista:

Bibliografiske detaljer
Udgivet i:	Cancer
Main Authors:	Vaz-Luis, Ines, O’Neill, Anne, Sepucha, Karen, Miller, Kathy D, Baker, Emily, Dang, Chau T, Northfelt, Donald W, Winer, Eric P, Sledge, George W, Schneider, Bryan, Partridge, Ann H
Format:	Artigo
Sprog:	Inglês
Udgivet:	2017
Fag:	Article
Online adgang:	https://ncbi.nlm.nih.gov/pmc/articles/PMC5517352/ https://ncbi.nlm.nih.gov/pubmed/28323331 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.30671
Tags:	Tilføj Tag Ingen Tags, Vær først til at tagge denne postø!

Survival Benefit Needed to Undergo Chemotherapy: Patients’ and Physicians’ Preferences: Patient and Physician Preferences instead of Patients’ and Physicians’ Preferences

Lignende værker